Novocure News

NovoCure Analyst Ratings

BenzingaMay 3 00:39

Analysts Offer Insights on Healthcare Companies: SELLAS Life Sciences Group (SLS) and NovoCure (NVCR)

TipRanksMay 3 00:30

Piper Sandler: Reiterates the NovoCure (NVCR.US) rating, adjusted from an increase to an increase rating, and the target price was adjusted from $25.00 to $28.00.

Zhitong FinanceApr 10 21:00

NovoCure Analyst Ratings

BenzingaApr 10 20:53

Wells Fargo Cuts Price Target on NovoCure to $42 From $49, Keeps Overweight Rating

MT NewswiresApr 4 00:55

NovoCure Analyst Ratings

BenzingaApr 4 00:42

Wells Fargo Maintains Overweight on NovoCure, Lowers Price Target to $42

BenzingaApr 4 00:43

NovoCure's TTFields Show Promise in METIS Study: Outperform Rating Reaffirmed With Raised Price Target

TipRanksMar 29 15:06

Analysts Offer Insights on Healthcare Companies: Moderna (MRNA), Argenx Se (ARGX) and NovoCure (NVCR)

TipRanksMar 28 17:01

NovoCure Analyst Ratings

BenzingaMar 28 01:43

HC Wainwright & Co. Maintains Neutral on NovoCure, Raises Price Target to $24

BenzingaMar 28 01:44

Nuanced Phase 3 Results Prompt Cautious Hold Rating for NovoCure's Stock

TipRanksMar 27 23:45

Analysts Offer Insights on Healthcare Companies: Intuitive Surgical (ISRG), CareMax (CMAX) and NovoCure (NVCR)

TipRanksMar 19 20:20

NovoCure Analyst Ratings

BenzingaMar 12 22:22

HC Wainwright & Co. Reiterates Neutral on NovoCure, Maintains $22 Price Target

BenzingaMar 12 22:23

Buy Rating Affirmed for NovoCure Amid Strong Q4 Performance and Promising Pipeline Developments

TipRanksFeb 26 12:28

NovoCure Analyst Ratings

BenzingaFeb 23 23:59

Piper Sandler Sticks to Its Buy Rating for NovoCure (NVCR)

TipRanksFeb 23 20:33

Buy Rating Affirmed for NovoCure Amid Positive Clinical Results and Solid Financial Performance

TipRanksFeb 23 19:00

HC Wainwright & Co. Maintains Buy on NovoCure, Raises Price Target to $22

BenzingaFeb 23 03:24